Interstitial Lung Disease Clinical Trials in San Francisco, California

3 studies are recruiting for interstitial lung disease in San Francisco, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease

    There is no standard of care therapy for patients with granulomatous-lymphocytic interstitial lung disease (GLILD) seen in common variable immunodeficiency (CVID). Abatacept has recently looked promising for the treatment of patients with complex CVID. This study is a multi-site, phase II, randomiz…

    Stage
    Phase 2
    Ages
    4 and older
    Site
    University of California, San Francisco, San Francisco, California
    Locations
    6 in total
    Run by
    Children's Hospital Medical Center, Cincinnati

    See if you can join NCT04925375 on ClinicalTrials.gov

  2. An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

    Study LTI-401 is an open-label, multicenter study which will evaluate the safety and tolerability of LIQ861 in subjects who have WHO Group 1 \& 3 PH.

    Stage
    Not phased
    Ages
    18 to 80
    Site
    UCSF, San Francisco, California
    Locations
    23 in total
    Run by
    Liquidia Technologies, Inc.

    See if you can join NCT06129240 on ClinicalTrials.gov

  3. Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease

    A study to identify patients with Rheumatoid Arthritis - Associated Interstitial Lung Disease (RA-ILD) that are at the highest risk for progression. The goal of the investigators is to recruit a group of patients with RA-ILD and collect information to help us understand more about disease progressi…

    Stage
    Not phased
    Ages
    18 to 90
    Site
    University of California San Francisco, San Francisco, California
    Locations
    4 in total
    Run by
    University of Colorado, Denver

    See if you can join NCT06397677 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.